A population-based series of 4,764 women from Piedmont, Italy, who were diagnosed with breast cancer during 1979–81 and for whom information on social and demographic factors was available, was followed-up for mortality until 1986 or 1987. Relative survival rates at one, three, and five years were 94.6, 81.6, and 71.1 percent, respectively, and were similar to those of other European series. Women aged 40–49 years at diagnosis experienced a better survival than women in other age groups. The mortality was highest between one and four years after diagnosis, and lowest between five and seven years. Survival rates were lowest for women above the age of 80, and single women had a worse prognosis than married women. Women with less than seven years of education had nonsignificantly lower survival rates than more educated women. No difference in survival was found according to occupation, size of town of residence, place of birth, or type of hospital.
Similar content being viewed by others
References
Sant M, Gatta G, Micheli A, et al. Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer 1991; 27: 981–4.
Cappa APM, Bertiond G, Colombo A, et al. Incidence of breast cancer in Piedmont: 1979–1981. Tumori 1987; 73: 219–27.
Muir C, Waterhouse J, Mack T, Powell J, Whelan S, Cancer Incidence in Five Continents, Volume V. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 88.
Azzopardi JG, Chepick OF, Hartmann WH, et al. The World Health Organization histological typing of breast tumors—Second edition. Am J Clin Pathol 1982; 78: 806–16.
World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. 9th Revision Conference. Geneva: WHO, 1978.
Golini A, Capocaccia R, Lori A, Verdecchia A. Tavole ridotte di mortalità per causa per le regioni e le ripartizioni italiane, 1980–82. Rome: Consiglio nazionale delle Ricerche. Istituto di Ricerche sulla Popolazione, 1987.
Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York; I. Wiley & Sons, 1980.
The LIFETEST procedure. In: SAS User's Guide: Statistics, Version 6, 4th Edition, Volume 2. Cary, NC: SAS Institute Inc., 1989; 1027–69.
Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187–220.
Hopkins A. P2L. Survival analysis with covariates: Cox models. In: Dixon WJ, Brown MB, Engelman L, et al, eds. BMDP Statistical Software. Berkeley, CA: University of California Press, 1983; 576–94.
Stoll BA. Does the malignancy of breast cancer vary with age? Clin Oncol 1976; 2: 73–80.
Langlands AO, Pocock SJ, Kerr GR, et al. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J 1979; ii: 1247–51.
Lees AW, Jenkins HJ, May CL, Cherian G, Lam EWH, Hanson J. Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 1989; 13: 143–51.
Registre Genevois des Tumeurs. Cancer à Genève: incidence, mortalité, survie 1970–1986. Genève: Registre Genevois des Tumeurs, 1988.
Levi F, Randimbison L, La Vecchia C. Breast cancer survival in relation to sex and age. Oncology 1992; 49: 413–7.
Centre de Lutte Contre le Cancer. Enquête Permanente sur le Cancer. Résultats et Analyse de la Survie. Paris: Doin Eds, 1986.
Division of Cancer Prevention and Control, National Cancer Institute Annual Cancer Statistics Review 1987. Bethesda, MD: US Department of Health and Human Services, 1988; NIH Pub. No. 88–2789.
Coebergh JWW, Kluck HM, Crommelin MA, et al. Trends in incidence, tumour size, mortality and survival of female breast cancer in an unscreened population in the Sooz-Area (the South East of the Netherlands), 1975–1987. Proceedings of the Meeting of the International Association of Cancer Registries, Maastricht, The Netherlands, 1989.
Ries LG, Pollack ES, Young JL. Cancer patient survival: surveillance, epidemiology, and end results program, 1973–79. JNCI 1983; 70: 693–707.
Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986; 315: 559–63.
Hibberd AD, Horwood LJ, Wells JE. Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years. Br Med J 1983; 286: 1777–9.
Høst H, Lund E. Age as a prognostic factor in breast cancer. Cancer 1986; 57: 2217–21.
Ribeiro GG, Swindell R. The prognosis of breast carcinoma in women aged less than 40 years. Clin Radiol 1981; 32: 231–6.
Mueller CB, Ames F, Anderson GD. Breast cancer in 3,558 women: age as a significant determinant in the rate of dying and causes of death. Surgery 1978; 83: 123–32.
Host H, Brennhovd IO, Mitchell L. Postoperative radiotherapy in breast cancer. Long term results from the Oslo study. Int J Radiat Oncol Biol Physiol 1986; 12: 727–32.
Vagerö D, Persson G. Cancer survival and social class in Sweden. J Epidemiol Comm Health 1987; 41: 204–9.
Karjalainen S, Pukkala E. Social class as a prognostic factor in breast cancer survival. Cancer 1990; 66: 819–26.
Dayal HH, Power RN, Chiu C. Race and socio-economic status in survival from breast cancer. J Chron Dis 1982; 35: 675–83.
Morrison AS, Lowe CR, MacMahon B, Yuasa S, Warram JH. Survival of breast cancer patients related to incidence risk factors. Int J Cancer 1972; 9: 470–6.
Greenberg ER, Vessey MP, McPherson K, et al. Body size and survival in postmenopausal breast cancer. Br J Cancer 1985; 51: 691–7.
Keirn W, Metter G. Survival of cancer patients by economic status in a free care setting. Cancer 1985; 55: 1552–5.
Kogevinas M. Longitudinal Study: Socio-demographic Differences in Cancer Survival, 1971–1983, England and Wales. London: Office of Population Censuses and Surveys, 1990; OPCS Series LS No. 5.
Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991; 49: 526–30.
Gordon N, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 1992; 135: 609–18.
Waxler-Morrison N, Hislop TG, Mears B, Kan L. Effects of social relationship on survival for women with breast cancer: a prospective study. Soc Sci Med 1991; 33: 177–83.
Boffetta P, Merletti F, Magnani C, Terracini B. A population-based study of prognostic factors in oral and oropharyngeal cancer. Eur J Cancer 1993 (in press).
Micheli A, Baldasseroni A, Bruzzi P, et al. La sopravvivenza per tumori dell'apparato respiratorio: dati italiani su base di popolazione e confronti internazionali. Ann Ist Sup Sanità 1992; 28: 71–90.
Mettlin CJ, Schoenfeld ER, Natarajan N, Suh O. Interhospital differences in cancer survival. J Chron Dis 1987; 40: 157–64.
Pawlega J, Urbanska A. Porównanie przezyc 5-letnich u rorych na nowotwory zlosliwe zamieszkalych w miescie i na wsi w latach 1972–1974. Nowotwory 1984; 34: 189–94.
Morrison AS, Black MM, Lowe CR, MacMahon B, Yuasa S. Some international differences in histology and survival in breast cancer. Int J Cancer 1973; 11: 261–7.
Kurtz JM, Jacqueanier J, Torhorst J. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989; 63: 1630–5.
Bonnet A, Roder D, Esterman A. Determinants of case survival for cancers of the lung, colon, breast and cervix in South Australia. Med J Aust 1984; 141: 705–9.
Carter CL, Allen C, Henson D. Five-year survival of breast cancer by histology, tumor size and extent of axillary lymph node involvement. Proceedings of the 14th International Cancer Congress 1986; 3: 53–63.
Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer. Cancer 1991; 68: 628–33.
Stenkvist B, Bengtsson E, Eriksson O, Jarkraus T, Nordin B, Westman-Naeser S. Histopathological systems of breast cancer classification: reproducibility and clinical significance. J Clin Pathol 1983; 36: 392–8.
Additional information
Dr Boffetta and Ms Winkelmann are with the Unit of Analytical Epidemiology, International Agency for Research on Cancer, Lyon, France. Drs Merletti, Magnani and Terracini are with the Unit of Cancer Epidemiology, Department of Biomedical Sciences and Human Oncology, University of Torino, Italy. Dr Cappa is with the Department of Pathology, Ospedale San Giovanni, Torino, Italy. Address correspondence to Dr Boffetta, Unit of Analytical Epidemiology, International Agency for Research on Cancer, 150, cours Albert-Thomas, F-69372 Lyon Cedex 08, France. This work was supported, in part, by a grant of the Italian Association for Research on Cancer.
Rights and permissions
About this article
Cite this article
Boffetta, P., Merletti, F., Winkelmann, R. et al. Survival of breast cancer patients from Piedmont, Italy. Cancer Causes Control 4, 209–215 (1993). https://doi.org/10.1007/BF00051315
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00051315